Open AccessTargeting the Canonical Nuclear Factor-κB Pathway with a High-Potency IKK2 Inhibitor Improves Outcomes in a Mouse Model of Idiopathic Pneumonia Syndrome
Author(s) -
K.A. Fowler,
C.M. Jania,
S.L. Tilley,
Angela PanoskaltsisMortari,
A.S. Baldwin,
J.S. Serody,
J.M. Coghill
Publication year - 2017
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/q730-2h29
Subject(s) - potency , pneumonia , medicine , pharmacology , chemistry , biochemistry , in vitro